Adverse Effects of Non-Stimulant ADHD Drugs: Atomoxetine, Alpha-Agonists

Title:Adverse Effects of Non-Stimulant ADHD Drugs: Atomoxetine, Alpha-Agonists

Volume: 7

Author(s): Myrtha Gregoire-Bottex*Katherine Soe

Affiliation:

• Department of Pediatrics and Adolescent Medicine, Western Michigan University, Homer Stryker M.D. School of Medicine, 1000 Oakland Drive, Kalamazoo, Michigan, MI,United States

Keywords: Mental health, children and adolescents, psychopharmacology, ADHD, attention deficit disorder, atomoxetine, alpha agonists.

Abstract: Background: Attention-deficit/hyperactivity disorder (ADHD) is a widespread diagnosis that affects many children and adolescents’ ability to function and succeed in academics, socially, or other situations. Non-stimulant medications have become widely utilized in this population, especially in stimulant-resistant individuals, whether due to poor efficacy or intolerance of side effects. However, these, too, harbor their own side effect profiles, including cardiovascular and sleep or energy level disturbances.

Objectives: We review the literature in discussion of the presentation and management of these adverse events for non-stimulant medications for ADHD, with a particular focus on atomoxetine and alpha agonists guanfacine and clonidine.

Conclusion: Non-stimulants are for the most part well tolerated but monitoring for cardiac and sleep difficulty is warranted.

Cite this article as:

Gregoire-Bottex Myrtha *, Soe Katherine , Adverse Effects of Non-Stimulant ADHD Drugs: Atomoxetine, Alpha-Agonists, Current Psychopharmacology 2018; 7 (1) . https://dx.doi.org/10.2174/2211556007666180328150248